HSV Type 2
Showing 1 - 25 of >10,000
NOWDx Test for the Diagnosis of Herpes Simplex Virus Type 2
Suspended
- HSV-2 Infection
- Herpes Simplex Virus Infection
- Diagnostic Test: NOWDx HSV-2 Test
-
Tempe, Arizona
- +2 more
Sep 29, 2022
Recurrent Genital Herpes Trial (UB-621)
Not yet recruiting
- Recurrent Genital Herpes
- UB-621
- (no location specified)
May 16, 2022
Genital Herpes Simplex Type 2 Trial (BNT163, Placebo)
Not yet recruiting
- Genital Herpes Simplex Type 2
- BNT163
- Placebo
- (no location specified)
Jun 21, 2022
Genital Herpes Trial in Seattle (acyclovir, valacyclovir)
Completed
- Genital Herpes
-
Seattle, WashingtonUniversity of Washington Virology Research Clinic
Nov 16, 2021
Herpes Simplex Trial in Tokyo (HSVTI Formulation 1, HSVTI Formulation 2, Placebo)
Not yet recruiting
- Herpes Simplex
- HSVTI Formulation 1
- +2 more
-
Tokyo, JapanGSK Investigational Site
Aug 4, 2023
Herpes Simplex-virus Type 1 (HSV-1) Reactivation
Recruiting
- Tracheobronchitis
- Herpes Simplex Infection
- Patients with herpes-simplex infection requiring bronchoscopy
-
Münster, GermanyUniversity Hospital Münster
Apr 11, 2022
Genital Herpes Trial in United States (mRNA-1608, BEXSERO)
Recruiting
- Genital Herpes
- mRNA-1608
- BEXSERO
-
Birmingham, Alabama
- +24 more
Sep 11, 2023
HSV, Herpes Labialis Trial in Saint Paul (Squaric Acid Dibutyl Ester)
Completed
- HSV
- Herpes Labialis
- Squaric Acid Dibutyl Ester
-
Saint Paul, MinnesotaPrism Clinical Research, LLC
Oct 5, 2021
Herpes Simplex 2, Meningitis, Viral Trial (Acyclovir 50 MG/ML, Placebo)
Not yet recruiting
- Herpes Simplex 2
- Meningitis, Viral
- Acyclovir 50 MG/ML
- Placebo
- (no location specified)
Jul 11, 2022
Advanced Colorectal Carcinoma Trial in Beijing (OH2, Capecitabine, Bevacizumab)
Not yet recruiting
- Advanced Colorectal Carcinoma
- OH2
- +2 more
-
Beijing, Beijing, ChinaNational Cancer Center/Cancer Hospital, Chinese Academy of Medic
Jan 28, 2023
Type 2 Diabetic Patients: Real-life Study on Effectiveness and
Not yet recruiting
- Diabete Type 2
- (no location specified)
Nov 2, 2023
Glucagon-like Peptide-1 Receptor Agonists According to Type 2
Recruiting
- Diabetes Mellitus, Type 2
- GLP-1 receptor agonist
-
Bari, ItalyAzienda Ospedaliero-Universitaria Policlinico Bari
Nov 4, 2023
Type 2 Diabetes Trial in Seoul (SGLT2 inhibitor)
Not yet recruiting
- Type 2 Diabetes Mellitus
- SGLT2 inhibitor
-
Seoul, Seodaemun-gu, Korea, Republic ofSeverance Hospital
Nov 17, 2023
Fatty Liver, Nonalcoholic Trial (SGLT2 inhibitor)
Not yet recruiting
- Fatty Liver, Nonalcoholic
- SGLT2 inhibitor
- (no location specified)
Oct 31, 2023
Type 1 Diabetes, Type 2 Diabetes Trial in Stockholm (N?-hydroxy-nor-arginine)
Recruiting
- Type 1 Diabetes
- Type 2 Diabetes
- Nω-hydroxy-nor-arginine
-
Stockholm, SwedenKarolinska Institutet
Apr 10, 2023
Herpes Simplex Trial in Lenexa, Rochester (Lower dose formulation of HSV vaccine (GSK4108771A), Low dose formulation of HSV
Terminated
- Herpes Simplex
- Lower dose formulation of HSV vaccine (GSK4108771A)
- +4 more
-
Lenexa, Kansas
- +1 more
Jun 24, 2021
Peripheral Circulatory Disorder Due to Type 2 Diabetes Trial (Buerger-Allen Exercise)
Not yet recruiting
- Peripheral Circulatory Disorder Due to Type 2 Diabetes Mellitus
- Buerger-Allen Exercise
- (no location specified)
Sep 26, 2023
Postural Control, Ankle and Trunk Proprioception in Type 2
Not yet recruiting
- Type2diabetes
- Semmes Weinstein Monofilament Test
- +5 more
- (no location specified)
Sep 17, 2023
Type 2 Diabetes Trial in Herlev (Time restricted eating)
Not yet recruiting
- Type 2 Diabetes
- Time restricted eating
-
Herlev, DenmarkSteno Diabetes Center Copenhagen
Nov 28, 2023
Diabetes, Type 2 Trial in Rawalpindi (Soleus Pushup Exercise, treadmill walk group 2)
Not yet recruiting
- Diabetes Mellitus, Type 2
- Soleus Pushup Exercise
- treadmill walk group 2
-
Rawalpindi, Punjab, PakistanRailway General Hospital
Sep 5, 2023
Mandala Painting, Type-2 Diabetic Patients Trial in Elazig (mandala painting)
Recruiting
- Mandala Painting
- Type-2 Diabetic Patients
- mandala painting
-
Elazıg, TurkeyFirat University
Oct 5, 2023